Articles
25.03.2021
Subscription style payment model

To tackle antibiotic resistance, novel antibiotics are being reserved as later-line therapy for more...

Read more
Articles
15.03.2021
Identifying market access challenges

Interactive eLearning is a fantastic way of engaging with small to large scale audiences that can be...

Read more
Articles
01.03.2021
NRDL expansions

China has the second largest healthcare system in the world. However, this market has been challengi...

Read more
Articles
11.02.2021
EMA Human Medicines

Last month, EMA published its overview of key recommendations for 2020 on the authorisation and safe...

Read more
Articles
26.01.2021
Improving access to innovative medicine in the UK

Following Brexit, the Medicines and Healthcare Regularoty Agency (MHRA) has become the UK's sole bod...

Read more
Articles
20.01.2021
What is a Value Proposition

For an audience to properly understand the value of a drug, evidence needs to be put into context.

Read more
Articles
16.12.2020
New PMPRB guidelines in Canada

The Patented Medicine Prices Review Board (PMPRB) has a mandate to ensure that patented medicines ar...

Read more
Articles
04.12.2020
What are the 5 Pricing and Market Access trends th...

Our experts predict the 5 trends they think will dominate the European pricing and market access lan...

Read more
Articles
30.11.2020
Pricing implications for cell and gene therapies

Cell and gene therapies - life saving opportunity for many patients

Read more
Articles
09.11.2020
NICE STA Process

A recent study assessed whether this new process has resulted in faster patient access.

Read more

Stay in the know, subscribe to our newsletter

Be the first to receive exclusive content on the latest from the pharmaceutical and market access sector.